The benefits of coronary bypass surgery last only as long asthe grafts continue to function. Aorta-to-coronary saphenous-veingrafts (see diagram), the most widely used type of bypass graft,have historically had an occlusion rate of 10 to 15 percentwithin a year after surgery. Beyond 5 years after surgery, graftatherosclerosis develops in substantial numbers of saphenous-veingrafts, and progressive graft failure occurs so that by 10 yearsafter placement, 60 to 70 percent of grafts are patent and halfof those have angiographic evidence of atherosclerosis. By 20years after placement, the rate of graft patency appears . . . [Full Text of this Article]
Source Information
From the Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland.
This article has been cited by other articles:
Semsroth, S., Stigler, R. G., Bernecker, O. Y., Ruttmann-Ulmer, E., Troppmair, J., Macfelda, K., Bonatti, J. O., Laufer, G.
(2009). Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts. Eur. J. Cardiothorac. Surg.
35: 515-520
[Abstract][Full Text]
Gardner, T. J.
(2007). Searching for the Second-Best Coronary Artery Bypass Graft: Is It the Radial Artery?. Circulation
115: 678-680
[Full Text]
Buxton, B. F., Durairaj, M., Hare, D. L., Gordon, I., Moten, S., Orford, V., Seevanayagam, S.
(2005). Do Angiographic Results From Symptom-Directed Studies Reflect True Graft Patency?. Ann. Thorac. Surg.
80: 896-901
[Abstract][Full Text]
Georghiou, G. P., Vidne, B. A., Dunning, J.
(2005). Does the radial artery provide better long-term patency than the saphenous vein?. ICVTS
4: 304-310
[Abstract][Full Text]
(2005). Patency of Radial-Artery vs. Saphenous-Vein Bypass Grafts. Journal Watch Cardiology
2005: 1-1
[Full Text]